Completed
T-Cell Infusion, Aldesleukin, and Utomilumab in Treating Patients With Recurrent Ovarian Cancer
NCT03318900
- Conditions
- Adnexal Diseases, COL6A3 Positive, Endocrine Gland Neoplasms, +16 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States